This review provides a novel perspective on the challenges of translating cardioprotection to the clinic, and present the case that optimal cardioprotection may require the combination of additive or synergistic multitarget therapies. This paper emerged as a consequence of a significant grant awarded to the Hatter Cardiovascular Institute by the European Union. J Am Coll Cardiol. 2019 Jan 8;73(1):89-99. doi: 10.1016/j.jacc.2018.09.086
UCL Queen Square Institute of Neurology achieves Gold in UCL Sustainability awards 2025
We're delighted to announce recognition of UCL Queen Square Institute of Neurology's commitment to sustainability at UCL’s Awards ceremony, taking home all Gold awards.
09 Jul 2025
Change the PATTERN: Addressing Unacceptable Behaviours in Academia
The PATTERN campaign is a collaborative initiative by UCL Queen Square Institute of Neurology and Koç University
08 Jul 2025
Global Business School for Health on the NHS 10 Year Plan for England
Professor Nora Colton, Director of the Global Business School for Health, responds to the recently published NHS 10 Year Plan for England
08 Jul 2025